Literature DB >> 12414753

Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance.

Francesco Broccolo1, Simona Bossolasco, Anna M Careddu, Giuseppe Tambussi, Adriano Lazzarin, Paola Cinque.   

Abstract

The frequency and clinical significance of detection of DNA of cytomegalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), HHV-7, and HHV-8 in plasma were investigated by PCR. The plasma was obtained from 120 selected human immunodeficiency virus (HIV)-infected patients, of whom 75 had AIDS-related manifestations, 32 had primary HIV infection (PHI), and 13 had asymptomatic infections. Nested PCR analysis revealed that none of the lymphotropic herpesviruses tested were found in patients with PHI, in asymptomatic HIV-positive individuals, or in HIV-negative controls. By contrast, DNA of one or more of the viruses was found in 42 (56%) of 75 patients with AIDS-related manifestations, including CMV disease (CMV-D) or AIDS-related tumors. The presence of CMV DNA in plasma was significantly associated with CMV-D (P < 0.001). By contrast, EBV detection was not significantly associated with AIDS-related lymphomas (P = 0.31). Interestingly, the presence of HHV-8 DNA in plasma was significantly associated with Kaposi's sarcoma (KS) disease (P < 0.001) and with the clinical status of KS patients (P < 0.001). CMV (primarily), EBV, and HHV-8 were the viruses most commonly reactivated in the context of severe immunosuppression (P < 0.05). In contrast, HHV-6 and HHV-7 infections were infrequent at any stage of disease. In conclusion, plasma PCR was confirmed to be useful in the diagnosis of CMV-D but not in that of tumors or other conditions possibly associated with EBV, HHV-6, and HHV-7. Our findings support the hypothesis of a direct involvement of HHV-8 replication in KS pathogenesis, thus emphasizing the usefulness of sensitive and specific diagnostic tests to monitor HHV-8 infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414753      PMCID: PMC130108          DOI: 10.1128/cdli.9.6.1222-1228.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  41 in total

1.  Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells.

Authors:  P Monini; F Carlini; M Stürzl; P Rimessi; F Superti; M Franco; G Melucci-Vigo; A Cafaro; D Goletti; C Sgadari; S Butto'; P Leone; C Chiozzini; C Barresi; A Tinari; A Bonaccorsi; M R Capobianchi; M Giuliani; A di Carlo; M Andreoni; G Rezza; B Ensoli
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives.

Authors:  M R Gopal; B J Thomson; J Fox; R S Tedder; R W Honess
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

3.  Detection of lymphotropic herpesvirus DNA by polymerase chain reaction in cerebrospinal fluid of AIDS patients with neurological disease.

Authors:  F Broccolo; R Iuliano; A M Careddu; R Trovato; S Lico; P L Blanc; F Mazzotta; L Ceccherini-Nelli
Journal:  Acta Virol       Date:  2000 Jun-Aug       Impact factor: 1.162

4.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

5.  Epstein-Barr virus in AIDS-related primary central nervous system lymphoma.

Authors:  E M MacMahon; J D Glass; S D Hayward; R B Mann; P S Becker; P Charache; J C McArthur; R F Ambinder
Journal:  Lancet       Date:  1991-10-19       Impact factor: 79.321

6.  Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.

Authors:  R Tedeschi; M Enbom; E Bidoli; A Linde; P De Paoli; J Dillner
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance.

Authors:  S Bossolasco; R Marenzi; H Dahl; L Vago; M R Terreni; F Broccolo; A Lazzarin; A Linde; P Cinque
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

8.  Cytomegalovirus and Kaposi's sarcoma in young homosexual men.

Authors:  W L Drew; M A Conant; R C Miner; E S Huang; J L Ziegler; J R Groundwater; J H Gullett; P Volberding; D I Abrams; L Mintz
Journal:  Lancet       Date:  1982-07-17       Impact factor: 79.321

Review 9.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections.

Authors:  M Brytting; W Xu; B Wahren; V A Sundqvist
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

View more
  7 in total

1.  Human herpesvirus 8 load in matched serum and plasma samples of patients with AIDS-associated Kaposi's sarcoma.

Authors:  Abeltje M Polstra; Remco Van Den Burg; Jaap Goudsmit; Marion Cornelissen
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.

Authors:  Ashok Cattamanchi; Misty Saracino; Stacy Selke; Meei-Li Huang; Amalia Magaret; Connie Celum; Lawrence Corey; Anna Wald; Corey Casper
Journal:  J Med Virol       Date:  2011-10       Impact factor: 2.327

3.  Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.

Authors:  Andrea Lisco; Jean-Charles Grivel; Angélique Biancotto; Christophe Vanpouille; Francesco Origgi; Mauro S Malnati; Dominique Schols; Paolo Lusso; Leonid B Margolis
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

Review 4.  Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment.

Authors:  Soren Gantt; Corey Casper
Journal:  Curr Opin Infect Dis       Date:  2011-08       Impact factor: 4.915

5.  Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Corey Casper; Elizabeth M Krantz; Lawrence Corey; Steven R Kuntz; Jie Wang; Stacy Selke; Shannon Hamilton; Meei-Li Huang; Anna Wald
Journal:  J Infect Dis       Date:  2008-07-01       Impact factor: 5.226

6.  Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.

Authors:  Soren Gantt; Ashok Cattamanchi; Elizabeth Krantz; Amalia Magaret; Stacy Selke; Steven R Kuntz; Meei-Li Huang; Lawrence Corey; Anna Wald; Corey Casper
Journal:  J Clin Virol       Date:  2014-03-13       Impact factor: 3.168

7.  Predictors of seropositivity for human herpesvirus type 8 in patients with mild cirrhosis.

Authors:  Kuo-Chih Tseng; Ming-Nan Lin; Tang-Yuan Chu; Jen-Pi Tsai; Cheng-Chuan Su
Journal:  Emerg Microbes Infect       Date:  2017-06-07       Impact factor: 7.163

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.